Author:
Bouys Lucas,Bertherat Jérôme
Abstract
AbstractFood-dependent Cushing’s syndrome (FDCS) is a rare presentation of
hypercortisolism from adrenal origin, mostly observed in primary bilateral
macronodular adrenal hyperplasia (PBMAH) but also in some cases of unilateral
adrenocortical adenoma. FDCS is mediated by the aberrant expression of
glucose-dependent insulinotropic peptide (GIP) receptor (GIPR) in adrenocortical
cells. GIP, secreted by duodenal K cells after food intake, binds to its ectopic
adrenal receptor, and stimulates cortisol synthesis following meals. FDCS was
first described more than 35 years ago, and its genetic cause in PBMAH has been
recently elucidated: KDM1A inactivation by germline heterozygous
pathogenic variants is constantly associated with a loss-of-heterozygosity of
the short arm of chromosome 1, containing the KDM1A locus. This causes
biallelic inactivation of KDM1A, resulting in the GIPR overexpression in
the adrenal cortex. These new insights allow us to propose the KDM1A
genetic screening to all PBMAH patients with signs of FDCS (low fasting cortisol
that increases after a mixed meal or oral glucose load) and to all first-degree
relatives of KDM1A variant carriers. Given that KDM1A is a tumor
suppressor gene that has also been associated with monoclonal gammopathy of
uncertain significance and multiple myeloma, the investigation of FDCS in the
diagnostic management of patients with PBMAH and further genetic testing and
screening for malignancies should be encouraged.